Market Overview:
The global infectious disease diagnostics testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for rapid and accurate diagnosis, and technological advancements in infectious disease diagnostics tests. The molecular diagnostic test segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing demand for molecular diagnostic tests due to their accuracy and speed of diagnosis.
Product Definition:
Infectious Disease Diagnostics Testing is the process of identifying and diagnosing infections. This testing is important because it can help to identify the cause of an infection and determine the best course of treatment.
Molecular Diagnostic Test:
The global molecular diagnostic test market is expected to witness significant growth over the forecast period owing to increasing prevalence of chronic diseases such as HIV, cancer, diabetes and other autoimmune disorders. Moreover, technological advancements in molecular diagnostics are also anticipated to boost the market growth.
Global Molecular Diagnostic Test Market by Product (Reagents & Consumables, Instruments), by Application (Oncology & Infectious Diseases).
POC Infectious Disease Diagnostics Test:
POC infectious disease diagnostics test refers to diagnostic procedures performed in the physician’s office or at the patient's bedside, which are less complicated and more cost-effective as compared to laboratory tests. POC tests are used for the diagnosis of common infections such as urinary tract infection, pneumonia, influenza pneumonia (flu), bronchitis, and others.
Application Insights:
The hospital application segment dominated the global market in 2017. The segment is expected to witness lucrative growth over the forecast period owing to an increase in patient admissions and a rise in prevalence of chronic diseases, such as HIV, tuberculosis, and malaria. In addition, factors such as government initiatives for improving healthcare infrastructure are likely to boost product demand globally.
The academic research application segment accounted for a significant share of the overall revenue in 2017 due to rising investments by governments across various countries toward development of novel diagnostics tools against infectious diseases that pose a threat to public health. For instance, Germany¢â‚¬â„¢s Ministry of Education and Research (MfR) has invested around USD 80 million toward development of diagnostic tests for priority infectious disease threats including HIV/AIDS & tuberculosis (HIV-TB).
Regional Analysis:
North America dominated the market in 2017. This can be attributed to the presence of a large number of infectious disease diagnostic testing companies, such as Quidel Corporation; Bio-Rad Laboratories, Inc.; and Beckman Coulter LLC. These companies are engaged in extensive R&D activities for developing novel tests for various infectious diseases.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing incidence rates of COVID-19 cases and other NTDs coupled with rising healthcare expenditure levels in this region. Furthermore, growing awareness about early diagnosis is anticipated favorably impact growth during the forecast period.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the infectious disease diagnostics testing market. The rise in global population and rapid urbanization has led to an increase in the number of people exposed to various pathogens, which is subsequently fueling the demand for diagnostic tests for infectious diseases.
- Technological advancements: The advent of novel technologies such as next-generation sequencing (NGS) and molecular diagnostics has revolutionized the field of infectious disease diagnostics, enabling faster and more accurate diagnosis. This is resulting in an increased demand for diagnostic tests, thereby driving growth in the market.
- Growing awareness about infections: There is a growing awareness among people about infections and their associated risks, which is leading to an increase in demand for diagnostic tests. This trend is particularly prominent among developed countries where there is a high prevalence of lifestyle-associated infections such as HIV/AIDS, tuberculosis (TB), and hepatitis C virus (HCV).
- Rising public healthcare expenditure: Governments around the world are investing heavily in public healthcare infrastructure with a view to providing better healthcare facilities to their citizens. This rising public expenditure on healthcare sector is aiding growth prospects for the Infectious Disease Diagnostics Testing market . 5) Emerging economies offer untapped potential: A large majority of emerging economies have a low penetration rate when it comes to infection diagnostics testing services owing to lack of awareness about these services as well as limited availability
Scope Of The Report
Report Attributes
Report Details
Report Title
Infectious Disease Diagnostics Testing Market Research Report
By Type
Molecular Diagnostic Test, POC Infectious Disease Diagnostics Test
By Application
Hospital, Academics Research, Others
By Companies
Abbott, bioMérieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
208
Number of Tables & Figures
146
Customization Available
Yes, the report can be customized as per your need.
Global Infectious Disease Diagnostics Testing Market Report Segments:
The global Infectious Disease Diagnostics Testing market is segmented on the basis of:
Types
Molecular Diagnostic Test, POC Infectious Disease Diagnostics Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Academics Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- bioMérieux
- Diasorin
- Roche Diagnostic
- Beckman Coulter
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Corgenix
- Diaxonhit
- Eiken Chemical
- EMD Millipore
- Epitope Diagnostic
- EUROIMMUN
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
Highlights of The Infectious Disease Diagnostics Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Molecular Diagnostic Test
- POC Infectious Disease Diagnostics Test
- By Application:
- Hospital
- Academics Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infectious Disease Diagnostics Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infectious Disease Diagnostics Testing is a process that helps to identify the presence of an infection and to determine the severity of that infection. This testing can be used to help diagnose infections such as pneumonia, bronchitis, or meningitis. It can also be used to help determine whether a person has contracted an illness from another person, or if they have developed an illness on their own.
Some of the major companies in the infectious disease diagnostics testing market are Abbott, bioMƒÂ©rieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International.
The infectious disease diagnostics testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infectious Disease Diagnostics Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Infectious Disease Diagnostics Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Infectious Disease Diagnostics Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Infectious Disease Diagnostics Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Infectious Disease Diagnostics Testing Market Size & Forecast, 2018-2028
4.5.1 Infectious Disease Diagnostics Testing Market Size and Y-o-Y Growth
4.5.2 Infectious Disease Diagnostics Testing Market Absolute $ Opportunity
Chapter 5 Global Infectious Disease Diagnostics Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Infectious Disease Diagnostics Testing Market Size Forecast by Type
5.2.1 Molecular Diagnostic Test
5.2.2 POC Infectious Disease Diagnostics Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Infectious Disease Diagnostics Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Infectious Disease Diagnostics Testing Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Academics Research
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Infectious Disease Diagnostics Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Infectious Disease Diagnostics Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Infectious Disease Diagnostics Testing Analysis and Forecast
9.1 Introduction
9.2 North America Infectious Disease Diagnostics Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Infectious Disease Diagnostics Testing Market Size Forecast by Type
9.6.1 Molecular Diagnostic Test
9.6.2 POC Infectious Disease Diagnostics Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Infectious Disease Diagnostics Testing Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Academics Research
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Infectious Disease Diagnostics Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Infectious Disease Diagnostics Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Infectious Disease Diagnostics Testing Market Size Forecast by Type
10.6.1 Molecular Diagnostic Test
10.6.2 POC Infectious Disease Diagnostics Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Infectious Disease Diagnostics Testing Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Academics Research
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Infectious Disease Diagnostics Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Infectious Disease Diagnostics Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Infectious Disease Diagnostics Testing Market Size Forecast by Type
11.6.1 Molecular Diagnostic Test
11.6.2 POC Infectious Disease Diagnostics Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Infectious Disease Diagnostics Testing Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Academics Research
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Infectious Disease Diagnostics Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Infectious Disease Diagnostics Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Infectious Disease Diagnostics Testing Market Size Forecast by Type
12.6.1 Molecular Diagnostic Test
12.6.2 POC Infectious Disease Diagnostics Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Infectious Disease Diagnostics Testing Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Academics Research
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Infectious Disease Diagnostics Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Infectious Disease Diagnostics Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Infectious Disease Diagnostics Testing Market Size Forecast by Type
13.6.1 Molecular Diagnostic Test
13.6.2 POC Infectious Disease Diagnostics Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Infectious Disease Diagnostics Testing Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Academics Research
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Infectious Disease Diagnostics Testing Market: Competitive Dashboard
14.2 Global Infectious Disease Diagnostics Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 bioMérieux
14.3.3 Diasorin
14.3.4 Roche Diagnostic
14.3.5 Beckman Coulter
14.3.6 Becton, Dickinson and Company
14.3.7 Bio-Rad Laboratories
14.3.8 Cavidi
14.3.9 Cepheid
14.3.10 Corgenix
14.3.11 Diaxonhit
14.3.12 Eiken Chemical
14.3.13 EMD Millipore
14.3.14 Epitope Diagnostic
14.3.15 EUROIMMUN
14.3.16 Gold Standard Diagnostics
14.3.17 Hologic
14.3.18 Immunetics
14.3.19 InBios International
